Back to Search
JOHN GROSSO, M.D.
M.D.
Otolaryngology Physician
NPI: 1912978057IndividualAccepts Medicare
Specialties, Licenses & Credentials
Otolaryngology PhysicianPrimary
Otolaryngology
Code: 207Y00000X
188915(NY)
CMS Specialties
PrimaryOTOLARYNGOLOGY
Education
OTHER
Class of 1986
Research & Publications (20)
Functionally distinct LAG-3 and PD-1 subsets on activated and chronically stimulated CD8 T cells.
PMID 19454660·J Immunol·2009
7-preclinical
Cyclophosphamide augments antitumor immunity: studies in an autochthonous prostate cancer model.
PMID 19435909·Cancer Res·2009
7-preclinical
Tumor recognition and self-recognition induce distinct transcriptional profiles in antigen-specific CD4 T cells.
PMID 19342643·J Immunol·2009
7-preclinical
Estimates of genetic trend for carcass traits in a commercial broiler line.
PMID 19283677·Genet Mol Res·2009
7-preclinical
Radiotherapy augments the immune response to prostate cancer in a time-dependent manner.
PMID 18561247·Prostate·2008
7-preclinical
Selecting and controlling API crystal form for pharmaceutical development--strategies and processes.
PMID 18946842·Curr Opin Drug Discov Devel·2008
6-review
Cutting edge: An in vivo requirement for STAT3 signaling in TH17 development and TH17-dependent autoimmunity.
PMID 17878325·J Immunol·2007
7-preclinical
Current immunotherapeutic strategies in prostate cancer.
PMID 18022549·Surg Oncol Clin N Am·2007
6-review
Strength and honor through the pharmaceutical industry's embrace of green chemistry?
PMID 17987518·Curr Opin Drug Discov Devel·2007
8-other
LAG-3 regulates CD8+ T cell accumulation and effector function in murine self- and tumor-tolerance systems.
PMID 17932562·J Clin Invest·2007
7-preclinical
Role of PD-1 and its ligand, B7-H1, in early fate decisions of CD8 T cells.
PMID 17392506·Blood·2007
7-preclinical
The challenges of process analytical technologies in chemical development.
PMID 16312144·Curr Opin Drug Discov Devel·2005
8-other
The expression of CCL2 by T lymphocytes of mammary tumor bearers: role of tumor-derived factors.
PMID 16243300·Cell Immunol·2005
7-preclinical
MUC1/sec-expressing tumors are rejected in vivo by a T cell-dependent mechanism and secrete high levels of CCL2.
PMID 15265901·J Immunol·2004
7-preclinical
N-Amination of pyrrole and indole heterocycles with monochloramine (NH2Cl).
PMID 14961694·J Org Chem·2004
8-other
A unique mucin immunoenhancing peptide with antitumor properties.
PMID 15520219·Cancer Res·2004
7-preclinical
Up-regulation of matrix metalloproteinase-9 in T lymphocytes of mammary tumor bearers: role of vascular endothelial growth factor.
PMID 14530359·J Immunol·2003
7-preclinical
[Assessment of the penetration of culture media in uterine cavity as an effect of cervical lavage before embryo transfer: prospective and observational study of samples obtained in hysterectomy].
PMID 11816524·Ginecol Obstet Mex·2001
8-other
Editorial Overview - The chemistry of process development.
PMID 19649895·Curr Opin Drug Discov Devel·2000
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 2 locations total
- Address
- 100 SUNRISE HWY
LINDENHURST, NY 11757 - Phone
- (631) 226-1800
Quick Facts
- NPI
- 1912978057
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 2
- Years in Practice
- 40
- Publications
- 20
Are you this provider?
Claim Your Profile